Parkinson's Disease Mechanisms and Treatments

146 ta ish

1. Effect of Electric Field on α-Synuclein Fibrils: Revealed by Molecular Dynamics Simulations

   Jamoliddin Razzokov, Sunnatullo Fazliev, Mukhriddin Makhkamov +3

   MaqolaOAOchiq kirishParkinson's Disease Mechanisms and TreatmentsInternational Journal of Molecular Sciences20235 iqtibos

   ABIABI:AkademIndex/2023.article.000430

2. Metabolically induced intracellular pH changes activate mitophagy, autophagy, and cell protection in familial forms of Parkinson's disease

   Nafisa R. Komilova, Plamena R. Angelova, Alexey V. Berezhnov +6

   MaqolaOAOchiq kirishAutophagy in Disease and TherapyFEBS Journal20212 iqtibos

   ABIABI:AkademIndex/2021.article.000165

3. Initial manifestations of Parkinson's disease in Uzbek nationality

   R. Juraev, E. Abdukodirov, R. Matmurodov +1

   MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20192 iqtibos

   ABIABI:AkademIndex/2026.other.515108

4. Gastrointestinal disturbances in various forms of parkinsonism

   O. Naimov, R. Matmurodov, E. Abdukodirov

   MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20192 iqtibos

   ABIABI:AkademIndex/2026.other.515109

5. Cardiovascular disorders in parkinsonism depending on the form of the disease

   R. Matmurodov, K. Khalimova, E. Abdukodirov

   MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20192 iqtibos

   ABIABI:AkademIndex/2026.other.515110

6. Constipation as a predictor of Parkinson's disease in persons of Uzbek nationality

   O. Naimov, E. Abdukodirov, R. Matmurodov +1

   MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20192 iqtibos

   ABIABI:AkademIndex/2026.other.515111

7. Character changes as a predictor of Parkinson’s disease in persons of Uzbek nationality

   R. Matmurodov, K. Khalimova, E. Abdukodirov

   MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20192 iqtibos

   ABIABI:AkademIndex/2026.other.515112

8. Hormonal pathogenetic effects and vascular-immunological aspects in secondary vascular parkinsonism

   D. Akramova, G. Rakhimbaeva

   MaqolaNuclear Receptors and SignalingParkinsonism & Related Disorders20181 iqtibos

   ABIABI:AkademIndex/2018.article.000489

9. New methods of treatment for vascular Parkinsonism and Parkinson's disease: Tempo-rhythmal correction combined with special exercise and music

   D. Akramova, G. Rakhimbaeva

   MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 iqtibos

   ABIABI:AkademIndex/2019.article.000935

10. Role of increased levels of endothelial factors in cognitive impairment in the Parkinson’s disease and vascular parkinsonism

    D. Akramova, G. Rakhimbaeva

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20191 iqtibos

    ABIABI:AkademIndex/2019.article.000940

11. Parkinson’s Disease in Central Asian and Transcaucasian Countries: A Review of Epidemiology, Genetics, Clinical Characteristics, and Access to Care

    Rauan Kaiyrzhanov, Mie Rizig, Akbota Aitkulova +9

    Sharh maqolaOAOchiq kirishParkinson's Disease Mechanisms and TreatmentsParkinson s Disease20191 iqtibos

    ABIABI:AkademIndex/2019.review-article.000009

12. Changes in the early stages of Parkinson's disease and vascular parkinsonism

    Muazzam Akramova, D. Akramova

    MaqolaNuclear Receptors and SignalingJournal of the Neurological Sciences20211 iqtibos

    ABIABI:AkademIndex/2021.article.008884

13. Aspects of the vegetative disorders occurrence in the Parkinson's disease and Vascular Parkinsonism

    S.-J. Khamdamov, D. Akramova

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20211 iqtibos

    ABIABI:AkademIndex/2021.article.009044

14. EVALUATION OF PRODROMAL STAGE BIOMARKERS IN PARKINSON'S DISEASE AND THEIR ROLE IN DISEASE PROGRESSION USE OF MODERN DIGITAL TECHNOLOGIES

    Khilola Maratovna Daminova, R. Matmurodov, D. Akramova +7

    MaqolaOAOchiq kirishParkinson's Disease Mechanisms and Treatments20221 iqtibos

    ABIABI:AkademIndex/2022.article.002730

15. Exploring α-synuclein stability under the external electrostatic field: Effect of repeat unit

    Javokhir Khursandov, Rasulbek Mashalov, Mukhriddin Makhkamov +3

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of Structural Biology20241 iqtibos

    ABIABI:AkademIndex/2024.article.001099

16. THE INFLUENCE OF MOTOR FLUCTUATIONS ON PSYCHOEMOTIONAL STATUS AND QUALITY OF LIFE IN PARKINSON'S DISEASE

    O. Naimov, Rustambek Matmurodov, B. Muminov

    MaqolaOAOchiq kirishParkinson's Disease Mechanisms and TreatmentsMedical science of Uzbekistan20251 iqtibos

    ABIABI:AkademIndex/2025.article.009891

17. «Brain—gut—microbiome» axis in patients with Parkinson’s disease

    Н. Г. Жукова, Z. F. Sayfitdinkhuzhaev, G.M. Israilova +5

    MaqolaParkinson's Disease Mechanisms and TreatmentsS S Korsakov Journal of Neurology and Psychiatry20251 iqtibos

    ABIABI:AkademIndex/2025.article.010426

18. Serum ferritin, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio are associated with levodopa-induced dyskinesia severity in Parkinson’s disease

    F.S. Saidvaliyev, Dilyora Pulatova, I.A. Kilichev +8

    MaqolaOAOchiq kirishParkinson's Disease Mechanisms and TreatmentsBMC Neurology20261 iqtibos

    ABIABI:AkademIndex/2026.article.016672

19. The influence of robotics and modern technologies to assist individuals with Parkinson's disease

    A. Kim, L. Alimbekova

    MaqolaNeurological disorders and treatmentsParkinsonism & Related Disorders20241 iqtibos

    ABIABI:AkademIndex/2026.other.468165

20. Sleep disorders as a predictor of Parkinson's disease in Uzbek nationality

    B. Amonov, Rustambek Matmurodov, E. Abdukodirov +1

    MaqolaParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20211 iqtibos

    ABIABI:AkademIndex/2026.other.515113

21. Psychosis in a Case of Schizophrenia and Parkinson’s Disease

    Benedikt Habermeyer, Stefan Kneifel, Irene Lotz-Bläuer +1

    BoshqaNeurological disorders and treatmentsJournal of Neuropsychiatry20080 iqtibos

    ABIABI:AkademIndex/2008.other.000002

22. α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease

    Masaaki Waragai, Kazunari Sekiyama, Akio Sekigawa +3

    Sharh maqolaOAOchiq kirishParkinson's Disease Mechanisms and TreatmentsInternational Journal of Molecular Sciences20100 iqtibos

    ABIABI:AkademIndex/2010.review-article.000001

23. Akiramine

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobParkinson's Disease Mechanisms and Treatments20120 iqtibos

    ABIABI:AkademIndex/2012.chapter.002170

24. Norbracteoline

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobCancer Treatment and Pharmacology20120 iqtibos

    ABIABI:AkademIndex/2012.chapter.002367

25. 14-Dehydrotalatisamine

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobParkinson's Disease Mechanisms and Treatments20120 iqtibos

    ABIABI:AkademIndex/2012.chapter.003763